MLB: Marlins put Cole Sulser on IL, recall Jimmy Yacabonis

Date:

Share post:


The Miami Marlins placed right-handed reliever Cole Sulser (right lat strain) on the 15-day injured list and recalled right-hander Jimmy Yacabonis from Triple-A, among several moves Wednesday.

The Marlins also placed RHP Edward Cabrera (right elbow tendinitis) on the 15-day IL and recalled southpaw Daniel Castano from Triple-A Jacksonville. The Marlins also moved LHP Jesus Luzardo to the 60-day IL to make room for Yacabonis on the 40-man roster.

Sulser’s and Cabrera’s stints are retroactive to Monday.

Sulser, 32, is 1-3 with a 3.86 ERA and two saves in 26 appearances this season, his first in Miami. The Marlins acquired Sulser from Baltimore in April. He last appeared Sunday, pitching 2/3 of an inning against Houston. He has a strikeout ratio of 10.0 per nine innings.

Yacabonis, 30, has yet to appear for the Marlins. He’s 3-5 with a 5.71 ERA in 57 career appearances (12 starts) for the Orioles and Seattle Mariners. Yacabonis is out of minor league options, meaning the Marlins must keep him on the active roster or designate him for assignment.

Cabrera, 24, is 2-1 with a 3.45 ERA in three starts this season.

Castano, 27, is 0-1 without an ERA in three appearances with the Marlins this season.

–Field Level Media

spot_img

Related articles

MLB: Braves place LHP Tyler Matzek (elbow) on 15-day injured list

The Atlanta Braves placed left-handed reliever Tyler Matzek, who has struggled since his return from Tommy John surgery,...

MLB: Doctor: Season debut of Dodgers’ Walker Buehler a success

Walker Buehler said he wished his first outing in almost two years for the Los Angeles Dodgers "could've...

MLB: Dodgers’ Japanese stars aim to take down Marlins

Two of the biggest contributors to the Los Angeles Dodgers' turnaround over the past two weeks will take...

MLB: Brewers pursue offensive improvement vs. Royals

The Milwaukee Brewers, in a two-day batting funk, hope to rebound on Tuesday after a taking a series-opening,...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.